MPM Oncology Innovations Fund, L.P. Plans to Sell Common Shares of Werewolf Therapeutics, Inc.

MPM Oncology Innovations Fund, L.P. has filed a notice to sell 28,657 common shares of Werewolf Therapeutics, Inc. The shares were acquired on May 4, 2021, through a private placement. The notice was signed by Kristen Laguerre on October 27, 2025, and the plan was adopted on September 24, 2025. The shares are to be sold on or around October 27, 2025, with an aggregate market value of $50,722.89. The transaction will be facilitated by Merrill Lynch. There were no securities sold in the past three months.